Order Total (1 Item Items):
Shipping Destination:
C Subathra Devi (13 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (13)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (11)
- As New, Fine or Near Fine (2)
- Very Good or Good (No further results match this refinement)
- Fair or Poor (No further results match this refinement)
- As Described (No further results match this refinement)
Binding
- All Bindings
- Hardcover (No further results match this refinement)
- Softcover (13)
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (4)
- Not Print on Demand (5)
Language (1)
Free Shipping
- Free Shipping to U.S.A. (No further results match this refinement)
Seller Location
Seller Rating
-
Multidrug Resistance of E.Coli from Urinary Tract Infected Patients
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
ISBN 10: 3659446335 ISBN 13: 9783659446337
Condition: New. pp. 68.
-
Nisin Based Lantibiotic Engineering: A novel approach on biopreservation
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659254738 ISBN 13: 9783659254734
Condition: New.
-
Nisin Based Lantibiotic Engineering: A Novel Approach On Biopreservation
Language: English
Published by Lap Lambert Academic Publishing, 2012
ISBN 10: 3659254738 ISBN 13: 9783659254734
Paperback. Condition: Brand New. 80 pages. 8.66x5.91x0.19 inches. In Stock.
-
Multidrug resistance of E.coli from urinary tract infected patients
Language: English
Published by LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659446335 ISBN 13: 9783659446337
paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Streptokinase-A novel clot buster: Studies on screening, strain development, production and optimization of streptokinase from ß-hemolytic streptococci
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659178683 ISBN 13: 9783659178689
Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Multidrug Resistance of E.Coli from Urinary Tract Infected Patients
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
ISBN 10: 3659446335 ISBN 13: 9783659446337
Condition: New. Print on Demand pp. 68 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
-
Multidrug Resistance of E.Coli from Urinary Tract Infected Patients
Language: English
Published by VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2013
ISBN 10: 3659446335 ISBN 13: 9783659446337
Condition: New. PRINT ON DEMAND pp. 68.
-
Nisin Based Lantibiotic Engineering: A novel approach on biopreservation
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659254738 ISBN 13: 9783659254734
Condition: New. Print on Demand.
-
Multidrug resistance of E.coli from urinary tract infected patients
Language: English
Published by LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659446335 ISBN 13: 9783659446337
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Naine S. JemimahMs. S. Jemimah Naine is currently working as Research associate at VIT University. Her research is inspired by naturally occurring antibiotics and antitumor compounds as well focused on molecular mechanisms involved i.
-
Nisin Based Lantibiotic Engineering: A novel approach on biopreservation
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659254738 ISBN 13: 9783659254734
Condition: New. PRINT ON DEMAND.
-
Streptokinase-A novel clot buster
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659178683 ISBN 13: 9783659178689
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: C. Subathra DeviDr.C.Subathra Devi and Dr.V.Mohanasrinivasan are currently working as Assistant Professor Senior at VIT University, Vellore, Tamil Nadu, India. Both of them are expertise in industrial enzymes especially on clot buste.
-
Nisin Based Lantibiotic Engineering
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659254738 ISBN 13: 9783659254734
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: V. MohanasinivasanDr.V.Mohanasrinivasan and Dr.C.Subathra Devi are currently working as Assistant Professor senior at VIT University, Vellore, Tamil Nadu, India. Both of them are expertise in industrial enzymes and proteins.Currently.
-
Streptokinase-A novel clot buster : Studies on screening, strain development, production and optimization of streptokinase from -hemolytic streptococci
Language: English
Published by LAP Lambert Academic Publishing, 2012
ISBN 10: 3659178683 ISBN 13: 9783659178689
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The leading cause of death in the world is coronary heart diseases. According to World Health Organisation (WHO) cardiovascular disease caused over 18 million deaths in the world in 2005. Of these deaths, 8 million (44%) occurred in people under 60 years of age. In the recent years, of the several thrombolytic agents used clinically, streptokinase is prone of the most-often employed, particularly of its lower cost when coded to others. This book deals with streptokinase as a clinically important and cost-effective plasminogen activator. Streptokinase is a non-proteolytic extracellular protein produced by Streptococcus species. It is the best, least expensive, efficient, highly potent plasminogen activator of fibrinolysis and routinely applied in clinical medicine for thrombolytic therapy for the treatment of diverse circulatory disorders. Presently there is about 80- 90% of demand for streptokinase. As per market research 2011 report, Asia, Europe and North America are the leading countries worldwide in manufacturing and supplying streptokinase. This book provides more information about hemolytic Streptococci and the strain improvement methods to enhance streptokinase production.
